Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | -1.81% | -10.47% | -43.97% |
Financials (USD)
Sales 2024 * | 65.38M | Sales 2025 * | 6.25M | Capitalization | 22.05M |
---|---|---|---|---|---|
Net income 2024 * | 24M | Net income 2025 * | -41M | EV / Sales 2024 * | 0.34 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.53 x |
P/E ratio 2024 * |
1.01
x | P/E ratio 2025 * |
-0.57
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.46% |
Latest transcript on MEI Pharma, Inc.
1 day | +3.44% | ||
1 week | -11.97% | ||
Current month | -17.25% | ||
1 month | -13.58% | ||
3 months | -33.00% | ||
6 months | -51.47% | ||
Current year | -42.93% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 3.25 | -1.81% | 12 047 |
24-04-17 | 3.31 | +3.44% | 9,086 |
24-04-16 | 3.2 | -1.54% | 16,466 |
24-04-15 | 3.25 | -0.61% | 13,289 |
24-04-12 | 3.27 | -9.92% | 22,242 |
Delayed Quote Nasdaq, April 17, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.93% | 22.05M | |
-1.78% | 41.36B | |
+47.70% | 41.3B | |
+4.01% | 39.61B | |
-15.14% | 25.62B | |
+3.16% | 24.09B | |
-24.08% | 18.38B | |
-2.67% | 11.82B | |
+24.76% | 11.85B | |
+7.01% | 11.07B |
- Stock Market
- Equities
- MEIP Stock